Increased Ca2+ sensitivity and protein expression of SERCA 2a in situations of chronic β3-adrenoceptor deficiency

This publication has 60 references indexed in Scilit:

• Enhanced Inhibition of L-type Ca2+ Current by β3-Adrenergic Stimulation in Failing Rat Heart
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure
  Nature Clinical Practice Cardiovascular Medicine, 2005
• Optimising the Use of ??-Adrenoceptor Antagonists in Coronary Artery Disease
  Drugs, 2005
• Control of 4E‐BP1 expression in mouse brown adipose tissue by the β₃‐adrenoceptor
  FEBS Letters, 2004
• Endogenous β₃-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure
  American Journal of Physiology-Heart and Circulatory Physiology, 2004
• Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload
  Cardiovascular Research, 2003
• Evidence for Calcineurin-mediated Regulation of SERCA 2a Activity in Human Myocardium
  Journal of Molecular and Cellular Cardiology, 2002
• Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium
  British Journal of Pharmacology, 2001
• Pharmacological characteristics and species‐related variations of β₃‐adrenergic receptors
  Fundamental & Clinical Pharmacology, 1995
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976